← FDA Drug Approvals (Drugs@FDA)

SUMATRIPTAN SUCCINATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2009-03-02

Drug application

FDA Application #
ANDA079242
Application type
Abbreviated New Drug Application (Generic)
Brand name
SUMATRIPTAN SUCCINATE
Generic name
SUMATRIPTAN SUCCINATE
Active ingredients
SUMATRIPTAN SUCCINATE
Dosage form
INJECTABLE
Route
SUBCUTANEOUS
Marketing status
Prescription
Sponsor
FRESENIUS KABI USA
Manufacturer
Fresenius Kabi USA, LLC
First approval
2009-03-02

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown